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the Arteriolar Red Cell Free Layer of
the Rat Cremaster Muscle
Ozlem Yalcin 1,2, Vivek P. Jani 2, Paul C. Johnson 2 and Pedro Cabrales 2*
1 Koç University School of Medicine, Sariyer, Istanbul, Turkey, 2Department of Bioengineering, University of California, San
Diego, San Diego, La Jolla, CA, United States
The endothelial glycocalyx is a complex network of glycoproteins, proteoglycans, and
glycosaminoglycans; it lines the vascular endothelial cells facing the lumen of blood
vessels forming the endothelial glycocalyx layer (EGL). This study aims to investigate the
microvascular hemodynamics implications of the EGL by quantifying changes in blood
flow hydrodynamics post-enzymatic degradation of the glycocalyx layer. High-speed
intravital microscopy videos of small arteries (around 35µm) of the rat cremaster
muscle were recorded at various time points after enzymatic degradation of the EGL.
The thickness of the cell free layer (CFL), blood flow velocity profiles, and volumetric
flow rates were quantified. Hydrodynamic effects of the presence of the EGL were
observed in the differences between the thickness of CFL in microvessels with an
intact EGL and glass tubes of similar diameters. Maximal changes in the thickness of
CFL were observed 40min post-enzymatic degradation of the EGL. Analysis of the
frequency distribution of the thickness of CFL allows for estimation of the thickness of the
endothelial surface layer (ESL), the plasma layer, and the glycocalyx. Peak flow, maximum
velocity, and mean velocity were found to statistically increase by 24, 27, and 25%,
respectively, after enzymatic degradation of the glycocalyx. The change in peak-to-peak
maximum velocity and mean velocity were found to statistically increase by 39 and
32%, respectively, after 40min post-enzymatic degradation of the EGL. The bluntness
of blood flow velocity profiles was found to be reduced post-degradation of the EGL, as
the exclusion volume occupied by the EGL increased the effective volume impermeable
to RBCs in microvessels. This study presents the effects of the EGL on microvascular
hemodynamics. Enzymatic degradation of the EGL resulted in a decrease in the thickness
of CFL, an increase in blood velocity, blood flow, and decrease of the bluntness of the
blood flow velocity profile in small arterioles. In summary, the EGL functions as amolecular
sieve to solute transport and as a lubrication layer to protect the endothelium from red
blood cell (RBC) motion near the vessel wall, determining wall shear stress.
Keywords: cell free layer, endothelial glycocalyx, endothelial surface layer, plasma layer, enzymatic degradation,
blood flow, shear stress, microcirculation
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INTRODUCTION
Blood is a multiphase fluid, consisting of red blood cells (RBCs),
plasma, proteins, and electrolyte, with nearly 45% of blood
volume occupied by RBCs. Consequently, the resistance to blood
flow and blood apparent viscosity are largely dependent on
the shear stress experienced by RBCs (Zhang et al., 2009).
Hydrodynamic forces during blood flow force RBC migration
away from the vessel wall, generating a RBC depleted zone
near the vessel wall, or cell free layer (CFL), and a RBC
packed core near the center of the blood vessel (Cokelet
and Goldsmith, 1991). The formation of the CFL in flowing
blood is an important hemodynamic feature of blood flow in
the microcirculation. The CFL corresponds to a low viscosity
zone, which acts as a lubricating hydrodynamic layer, reducing
resistance to flow between the central core of RBCs and
the vessel wall (Reinke et al., 1987; Zhang et al., 2009).
The thickness of the CFL is proportional to the yield stress
of the flowing fluid and depends on the hematocrit (Hct),
RBC aggregation, vessel geometry, the migration forces driving
the RBCs to away from the vessel wall, and the endothelial
glycocalyx.
The endothelial cells lining the luminal side of blood
vessels are covered with membrane-bound macromolecules,
glycoproteins, and proteoglycans known as the endothelial
glycocalyx. The polyanionic nature of the glycocalyx
is a consequence of the glycoproteins, bearing acidic
oligoasaccharides and terminal sialic acids (SAs) and the
proteoglycans, with their glycosaminoglycan (GAG) side chains,
that compose it. As such, under physiological conditions the
glycocalyx is negatively charged. Association of the polyanionic
components of the endothelial glycocalyx layer (EGL) with
blood-borne molecules results in an extended endothelial
surface layer (ESL) that arises from the EGL (Adamson and
Clough, 1992; Pries et al., 2000). Enzymes and their inhibitors,
growth factors, plasma proteins, cytokines, cations, and water,
all associate with this matrix of biopolyelectrolytes (Bernfield
et al., 1999; Osterloh et al., 2002). In addition to glycoproteins,
proteoglycans and GAGs, the EGL mainly consists of keratan
sulfate, chondroitin sulfate, dermatan sulfate, heparan sulfate,
and hyaluronan. The EGL provides selective vasoprotective
barrier properties of the vascular wall against vascular leakage,
platelet, and leukocyte adhesion (Nieuwdorp et al., 2005). In
intact blood vessels, the glycocalyx has an important role in
a wide range of physiological processes including increasing
vascular permeability, sensing shear stress, and impeding
leukocyte and platelet adhesion to the vessel wall (Nieuwdorp
et al., 2005; Weinbaum et al., 2007). In vivo observations
have reported a structure named the ESL, which includes the
glycocalyx and other plasma proteins attached to the glycocalyx
(Pries et al., 2000). The ESL thickness has been reported to be
approximately range from 0.5µm to over 1µm (Weinbaum
et al., 2007). In general, reports suggest that the ESL thickness
varies in different regions of the vascular network (Becker et al.,
2010). It is well known that an ESL exists but in vivo thickness of
the layer is controversial because of the different values from the
different techniques in the literature.
This study was conducted to evaluate the effect of the EGL
on microvascular blood flow in small arterioles using the rat
cremaster muscle preparation. The endothelial glycocalyx was
enzymatically degraded by enzymatic degradation via systemic
infusion of enzymes to cleave specific GAGs (heparinase,
chondroitinase, and hyaluronidase). The degradation of the EGL
did not produce major changes in the main systemic parameters
of the studied animals. We evaluated the hypothesis that as the
EGL determines CFL dynamics, blood flow, and shear rates,
it consequently affects blood apparent viscosity. By degrading
the EGL, we investigate in vivo the non-Newtonian relationship
between shear rate and shear stress of blood flow in microvessels
to establish the implications of the EGL on vascular resistance.
Responses to changes in the integrity of the EGL were studied for
individual arterioles using intravital microscopy and capturing
high-speed video recordings to measure the CFL thickness and
blood flow velocity. In vivo blood flow measurements were
combined with CFL thickness assessment with sufficient spatial
and temporal resolution.
MATERIALS AND METHODS
Animal Model and Tissue Preparation
Sprague-Dawley rats (Harlan Laboratories, Livermore, CA)
weighing 150–185 g were used to perform the studies.
Experiments were approved by the Institutional Animal
Care and Use Committee at University of California San Diego
and conducted in accordance with the Guide for the Care
and Use of Laboratory Animals (National Research Council
Committee US, 2010). The cremaster muscle model, for which
the complete surgical preparation is elsewhere described in
detail, was used for observation of the microcirculation (Baez,
1973). Briefly, 60 mg/kg pentobarbital sodium was injected ip
for anesthesia of rats. Throughout the experiment, additional
anesthesia was administered as needed. Blood withdrawals and
pressure measurements were obtained from the catheterized
femoral artery. Catheterization of the right jugular vein was
utilized for fluid and anesthesia administration. The animal
was positioned on a stage where the cremaster muscle was
gently lifted and secured by sutures on a temperature controlled
plexiglass pedestal (Physitemp Instruments, Inc. Clifton, NJ).
Plastic film was used to cover the exposed muscle (Saran,
Dow Corning, Indianapolis, IN). Arteriole responsiveness to a
physiological stimulus was tested by topically applying adenosine
(10−4 M) mixed with suffusate under the polyvinyl film. The
experimental procedures were started after 20–30min after the
adenosine was washed away. Non-reactive vessels or vessels
not recovering baseline diameter within this time period were
excluded from study. Similarly, at the end of the study, adenosine
(10−4 M) was reapplied and non-reactive vessels, or vessels that
had not recovered their diameter prior adenosine application
20min after washing it, were excluded from study. At the end of
the experiment, animals were euthanized.
Intravital Microscopy
The experimental setup consisted of an intravital microscope
(Olympus-BX51WI) equipped with a matching long working
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distance condenser (NA = 0.8, Thorlabs, Newton, NJ). Two
magnifications of 2X and 1.5X were installed between the
objective (40X, LUMPFL-WIR, NA = 0.8; Olympus) and the
high-speed camera, providing a total magnification of 1200X
with an equivalent resulting pixel size of 0.125µm relative to the
object plane. A mercury arc lamp (100W, Walker Instruments,
Scottsdale, AZ) was used to illuminate the tissue. A 400-
nm interference filter (Spectra Physics, no. 59820) was placed
above the condenser in the light path to maximize contrast
between blood and the surrounding tissue. A high-speed video
camera (Fastcam 1024 PCI, Photron USA), equipped with a one-
megapixel chip was used for video recording. Additionally, all
videos were recorded between 2,000 and 3,000 frames per second
and the camera shutter speed was optimized to obtain the highest
quality image possible.
Experimental Protocol
As blood rheology is strongly influenced by hematocrit (Hct),
the systemic Hct of all animals included in the study was
standardized to 40% Hct via hemodilution when needed.
Hemodilution was accomplished by concurrent withdrawal of
blood from the arterial catheter and infusion of 5% wt/v human
serum albumin solution (ABO Pharmaceuticals, San Diego, CA)
using the venous catheter. Vessel diameter was continuously
monitored, and video recordings for velocity measurements were
collected at selected time points.
Microvascular Diameter and Cell Free
Layer (CFL) Thickness
The analysis of intensity along a video raster line across the
vessel was used to determine the vessel diameter (D), RBC
column width, and CFL thickness. Detailed information of the
algorithm has been previously described (Kim et al., 2006). The
CFL thickness was approximated as the distance between the
outer edge of the RBC core and the vessel wall. CFL analysis was
performed on both sides of the vessel using a sequence of 1,600
consecutive video frames. Diameter and CFL were measured
over a 0.8 s time. Vessel diameter was averaged over this period,
and only diameters with standard deviation close to zero were
used. Diameter measurements with high standard deviation were
discarded and repeated, as diameters were not expected to change
over this short period. CFL temporal variation (TV) was defined
as the standard deviation of the CFL measurements in an entire
image sequence divided by the time elapsed (Kim et al., 2007).
Blood Velocity Profiles
The instantaneous blood flow velocities at different points along
the radial direction of the micro-vessel were determined from
velocity profiles measured using 2D cross correlation. Briefly,
images are segmented (10 × 10 pixels), and the displacement
of each segment relative to the subsequent image is calculated
based on the maximum correlation coefficient, from which cross
correlation coefficients are calculated. Velocity was calculated as
the longitudinal displacement multiplied by the frame rate (2,000
fps). This approach provides a spatial velocity profile for every
set of two consecutive frames and allows for a range of velocity
measurements between 0.3 and 250 mm/s. Mean velocity was
calculated as the arithmetic mean of the velocity profile. Blood
flow (Q) was calculated assuming Poiseuille’s flow, as:
Q =
piD4V
4
(1)
where D is the vessel diameter, and V is the mean blood flow
velocity.
Enzymatic Degradation of the Endothelial
Glycocalyx
Enzymatic degradation of the glycocalyx in the cremaster muscle
is achieved by systemic infusion of specific enzyme cocktail.
Specific GAGs were cleaved by the enzymes heparinase III
(50 U/mL), chondroitinase ABC (10 U/mL) and hyaluronidase
(3,000 U/mL) and were given in bolus doses via the femoral
catheter (Cabrales et al., 2007). CFL recordings were made at
5, 20, 40, and 60min after enzyme treatment and for a sham
group at the same timepoints. This treatment was selected as it
is reported not to produce any significant changes in the main
systemic parameters of the studied animals.
Estimation of the Endothelial Glycocalyx
Thickness
EGL thickness was estimated by subtracting the 99% confidence
interval of the CFL in a glass tube, in which only fluid
hydrodynamic forces from the 99% confidence interval measured
in vivo. As the CFL is the sum of the effects of the EGL
and the fluid hydrodynamic forces, subtraction of the two
distributions will yield an approximation of the thickness of the
endothelial glycocalyx. However, because the glycocalyx itself has
hydrodynamic forces associated with its presence, it is impossible
to exactly determine the thickness of the glycocalyx utilizing this
methodology.
Velocity Profiles
Velocity profiles were determined via auto-correlation of high-
speed intravital microscopy videos before and after enzymatic
degradation of the endothelial glycocalyx, and results were fit to
the following model:
υ (r) = υmax
(
1−
∣∣∣ r
R
∣∣∣K
)
(2)
where v(r) is the spatial velocity profile, vmax is the maximum
velocity of the profile, R is the radius of the vessel, and K is the
blunting coefficient. Least squared fits were determined using the
MATLAB Curve Fitting Toolbox (Mathworks, 2017).
Statistical Analysis
Results are presented asmean± standard deviation. All statistical
calculations and graphics were performed with a commercially
available software package (Prism 7.0, GraphPad). To test the
normality of the distributions, the D’Agostino and Pearson
Normality test was used. Group’s comparisons were performed
for diameter and CFL thickness data utilizing both ordinary one-
way ANOVA. In this case, the assumption of normality in the
ANOVA test-statistic was validated via the non-parameterized
Frontiers in Physiology | www.frontiersin.org 3 March 2018 | Volume 9 | Article 168
Yalcin et al. Glycocalyx Effects on Microhemodynamics
Geisser Greenhouse test to test for sphericity. As the sphericity
metric for all comparisons approached 1, it can be concluded that
the ANOVA test statistic is Gaussian, even though the original
distributions for CFL thickness were non-Gaussian. Pair-wise
comparisons for velocity and flow data were performed with a
Mann-Whitney U-Test. Variance comparisons were performed
utilizing the F-test. For all tests, P < 0.05 was accepted as
statistically significant. Histograms and cumulative distribution
functions (CDFs) of the CFL were numerically determined and
analyzed at different time points. The maximum likelihood of the
CFL thickness was approximated as the inflection point of the
CDF. Ninety nine confidence intervals are presented from the
point at which P = 0.01 to the maximum likelihood determined
from the CDF. A Bland Altman analysis was utilized to analyze
variations in CFL thickness over time as compared to a glass tube:
S
(
x, y
)
=
(
S1 + S2
2
, S1 − S2
)
(3)
Where S1 is the thickness of the CFL at baseline and after
enzymatic degradation, and S2 is the thickness of the CFL in a
glass tube. All animals passed the Grubbs’ test, ensuring that all
the measured values at baseline were within a similar population
(P < 0.05).
RESULTS
A total of 27 animals (n = 27) were entered into the study, two
or three arteries were selected in each animal. After application
of the systemic and vessel reactivity inclusion criteria, data
from 20 animals (n = 20) were in included in the results.
We found no significant differences in the systemic parameters,
confirming that the EGL degradation only had microvascular
effects without causing systemic hemodynamic disturbance.
Additionally, Table 1 presents the thickness of the CFL after
enzymatic treatment and in a Control group over time. As
demonstrated in the sham group variations in the CFL thickness
were within ±5% of that at baseline, while the CFL thickness
decreased by 11.4% 40min after enzymatic treatment. These
results provide sufficient evidence that changes in the thickness
of the CFL were likely due to enzymatic treatment and not due to
spontaneous variations.
CFL Analysis for a Single Blood Vessel
Initial arteriole diameter was 34–36µmandmaximally decreased
to 32–33µm 20min after enzymatic degradation of the
glycocalyx. No change in diameter was detected in the Control
group overtime relative to baseline. The maximal change in
diameter measured was < 5% from baseline diameter at 20min
after enzymatic degradation of the glycocalyx. The reduction in
diameter increases the fraction of the radius of the arterioles
occupied by the CFL from 5.8 to 6.1%. Image analysis of high-
speed intravital microscopy videos recorded for a single arteriole
was quantified in terms of the CFL thickness at different time
points after infusion of the enzyme cocktail (Figure 1). Thickness
of the CFL is presented in Figure 1A. The CFL thickness was
found to be statistically different from baseline at all-time points.
The median value of the CFL thickness decreased to 86% of
that at baseline at 40min after enzymatic degradation of the
glycocalyx. Distributions of the CFL thickness were also found to
deviate from a standard Gaussian to a right-skewed distribution,
indicative of the vessel wall acting as a physical boundary to
blood flow as the distributions failed the Kolmogorov-Smirnov
and the D’Agostino and Pearson Normality Test, P < 0.001
(Figures 1B,C). Differences in the variances of the distributions
were also found to be statistically significant. The 99% confidence
interval of the CFL thickness is presented in Figure 1D. The
cumulative fractions of the CFL over time compared to baseline
are presented in Figure 2. The 99% confidence interval of the
CFL was found to decrease from δ ∈ [1.50µm, 2.25µm] to
a low of δ ∈ [0.50µm, 1.75µm] at a time of 40min, where δ
is the thickness of the CFL. Additionally, thickness of the CFL
increased between 40 and 60min to δ ∈ [1.50µm, 2.25µm],
indicating recovery of the endothelial glycocalyx.
CFL Analysis From Multiple Blood Vessels
Changes in vascular tone for all the 46 arterioles (ranging from
30 to 36µm) from 20 different animals were not statistically
significant at the different time points compared to baseline.
The thickness of the CFL for the 46 arterioles is presented
in Figure 3A. Similar to the analysis of a single vessel, there
were statistically differences in the CFL thickness over all time
points compared to baseline. The CFL thickness does not fit a
Gaussian (normal) distribution, indicating random variation, as
the distributions failed the D’Agostino and Pearson Normality
Test, P < 0.001. The distribution of the CFL thickness was
observed to be right-skewed, which is due to the vessel wall acting
as a physical barrier to the thickness of the CFL (Figures 3B,C).
The 99% confidence interval of the CFL thickness for 46 arterioles
is presented in Figure 3D. The cumulative fractions of the CFL
over time compared to baseline are showed in Figure 4. The 99%
confidence interval of the CFL was found to decrease from δ ∈
[1.00µm, 2.25µm] to a low of δ ∈ [0.50µm, 1.75µm] at a time
of 40min. Additionally, thickness of the CFL increased between
40 and 60min to of δ ∈ [1.00µm, 2.75µm]. For reference, the
TABLE 1 | Thickness of the CFL after enzymatic treatment and control groups.
Baseline 5 min 20 min 40 min 60 min
Control (% change
from BL)
2.04 ± 0.01µm (0.0%) 2.13 ± 0.01µm (+4.6%) 2.11 ± 0.01µm (+3.4%) 2.06 ± 0.02µm (+0.8%) 1.98 ± 0.01µm (−3.1%)
Enzyme treatment
(% change from BL)
2.76 ± 0.02µm (0.0%) 2.93 ± 0.02µm (+7.8%) 2.50 ± 0.01µm (−5.8%) 2.42 ± 0.02µm (−11.4%) 3.22 ± 0.02µm (+18.4%)
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FIGURE 1 | Single microvessel CFL thickness during enzymatic degradation of the EGL: (A) CFL thickness over time after enzyme infusion. The changes in the mean
CFL were found to be statistically significant (‡P < 0.05) at all-time points. (B) Histograms of CFL thickness over time after enzyme infusion. (C) Cumulative
distribution functions (CDF) of CFL thickness over time after enzyme infusion. (D) One tailed 99% confidence interval of CFL over time after infusion. The left hand
bound was determined as the point on the CDF at which P < 0.01, and the right hand bound was determined as the inflection point of the CDF (see
Supplemental Figure 1). (‡P < 0.05) compared to baseline.
thickness of the CFL in a glass tube was measured and the 99%
confidence interval was found to be δ ∈ [0.50µm, 1.75µm]. In
addition, the size of the 99% confidence interval of the CFL was
found the statistically larger than that at baseline via the F-test,
indicating unequal spatial recovery of the EGL after enzymatic
degradation.
EGL Thickness
Glycocalyx thickness was found to be approximately 0.50 ±
0.02µmandwas found to degrade to 0.25± 0.02µm20min after
infusion of the enzyme cocktail (Figures 3A, 4).
Variances in CFL Thickness Over Time
Variations in the CFL thickness over time before and after
enzymatic degradation of the CFL are shown in Figure 5A and
compared to those in a glass tube of equal diameter in Figure 5B
via a Bland-Altman plot. The mean deviation of the CFL
from that of a glass tube statistically decreased after enzymatic
degradation of the EGL. The size of the 95% confidence interval
did not change after degradation of the EGL. The negative end
of the 95% confidence interval changed, while the positive end
remained constant, determined by the presence of the vessel wall.
Comparing the variance of the CFL thickness from the blood
vessel to the glass tube before and after enzymatic degradation of
the glycocalyx, shows that degradation of glycocalyx increases the
difference in the CFL between the blood vessel and the glass tube.
The positive end of the difference remained unaltered, because it
is indicative of the vessel wall, whereas the negative boundary of
the difference shows the increased erratic variations in the CFL of
the blood vessel after the degradation of the glycocalyx.
Blood Flow and Blood Velocity Over Time
Max blood flow, max blood velocity, and mean velocity were
found to statistically increase by 24, 27, and 25%, respectively,
after enzymatic degradation of the EGL. Additionally, the change
in peak-to-peak max velocity and peak-to-peak mean velocity
between were found to statistically increase by 39 and 32%,
respectively, after enzymatic degradation of the EGL. However,
the increase in the change in peak-to-peak flow was not found
to be statistically significant after degradation of the EGL. Results
are summarized in Figures 6, 7A,B.
Velocity Profiles After Enzymatic
Degradation of the EGL
Velocity profiles before and after degradation of the EGL
are presented in Figures 7C,D. During systole, the blunting
coefficient decreased from 4.1 ± 0.4 to 3.5 ± 0.7 after
enzymatic degradation of the EGL. Similarly, during diastole, the
blunting coefficient decreased from 3.1 ± 0.6 to 2.2 ± 0.6 after
enzymatic degradation of the EGL. Thus degradation of the EGL
decreasedmicrovessel blood velocity bluntness and a shift toward
Poiseuille flow.
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FIGURE 2 | Single microvessel cumulative distribution function during enzymatic degradation of the EGL: CDFs at baseline and at (A) 5min, (B) 20min, (C) 40min,
and (D) 60min after enzyme infusion. The blue bonding box represents the portion of the CFL influenced by the glycocalyx and its associated hydrodynamic forces,
and the green bounding box represents the one-tailed 99% confidence interval of the CFL thickness (see Supplemental Figure 2).
DISCUSSION
The principle finding of this study is that enzymatic degradation
of the EGL resulted in a statistically decrease in the CFL thickness,
as well as a statistical increase in max blood flow, and max
and mean blood velocity. Enzymatic degradation of the EGL
also decreased the blunting of the blood velocity profile in
arterioles, indicating a shift toward Poiseuille flow. Previous
studies have posed models to explain the hydrodynamic and
physical forces associated with the EGL (Pries et al., 1990, 1997;
Secomb et al., 1998; Long et al., 2004; Weinbaum et al., 2007).
Our study provides in vivo validation of the hydrodynamic
effects of the EGL on blood flow. Changes in the thickness
of the CFL during enzymatic degradation compared to the
CFL thickness in glass tubes confirms the physical presence
of the glycocalyx and the hydrodynamic lubricating layer it
produces, and allows for estimation of the apparent thickness
(0.5µm). Literature and mathematical models describe the
effects of enzymatic degradation of the EGL on microvascular
blood flow as the balance between two opposing forces. As
the glycocalyx is a physical barrier to blood flow, it decreases
the effective diameter, or the diameter accessible to blood
flow, of the lumen. In this schema, degradation of the EGL
increases the effective diameter of the lumen, thus decreasing
vascular resistance and consequently decreasing blood flow.
However, the anionic character of the glycocalyx imparted to
it by the glycoproteins and glycosaminoglycans that constitute
it are a source of electrical forces that effectively increase
the apparent viscosity of blood by forcing negatively charged
RBCs toward the center of the lumen, known as the electro-
viscous effect. In this schema, degradation of the EGL will
decrease the apparent viscosity of blood, increasing blood
flow. The effects of the EGL on microvascular blood flow
are a summation of both phenomena. As observed in this
study, in the case of a 34µm, blood flow was found to
increase with enzymatic degradation of the EGL, indicating
that electro-viscous effects are more dominant for arterioles
of this size. The thickness of the EGL and ESL are a small
fraction of the arteriole lumen diameter, which increases as the
arteriole diameter decreases. Therefore, degradation or damages
in the EGL have different effects on microvascular blood flow
depending on the arteriole diameter, as the electro-viscous
effect of the EGL on blood flow becomes less significant in
smaller arterioles. The small changes in diameter induced by
the enzymatic degradation of the EGL are not responsible
for the changes in the CFL thickness or the hemodynamics
measured in the study; although, the vasoconstriction induced
by the degradation of the EGL is a confounding effect that
overestimates the fraction of the arteriole lumen occupied
EGL.
The analyzed video recordings determined arteriolar blood
flow using spatial cross-correlation analysis, which allows for
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FIGURE 3 | Mean CFL thickness during enzymatic degradation of the EGL: (A) CFL thickness over time after enzyme infusion. The changes in the mean CFL were
found to be statistically significant (‡P < 0.05) at all-time points. (B) Histograms of CFL thickness over time after enzyme infusion. For individual histograms, see
Supplemental Figure 2. (C) Cumulative distribution functions (CDF) of CFL thickness over time after enzyme infusion. (D) One tailed 99% confidence interval of CFL
over time after infusion. The left hand bound was determined as the point on the CDF at which P < 0.01, and the right hand bound was determined as the inflection
point of the CDF (see Supplemental Figure 1). The thickness of the EGL (indicated as dotted line) was approximated by correcting the CFL distributions with that
measured for a glass tube, in which only fluid hydrodynamic forces are present. (‡P < 0.05) compared to baseline.
measurements of blood flow velocities up to 40 mm/s with a
precision that ranges between 0.5 and 1µm (Ortiz et al., 2014)
Arteriolar diameters exhibited minimal variations during the
experiments after enzyme treatment. As such, arteriolar blood
flow velocity was used to estimate relative changes in network
flow resistance. Enzymatic degradation of the EGL decreases
the plug flow behavior of the blood velocity profile shifting
toward pipe flow behavior, as demonstrated by the decreasing
magnitude of the blunting coefficient (Figures 7C,D). These
results are once again in accordance with the electro-viscous
effects produced by the EGL as the electrical forces present in the
CFL invalidate the no-slip boundary condition that defines pipe
flow. As degradation of the EGL decreases the magnitude of the
electrical forces present in the CFL, pipe flow is observed after
degradation of the glycocalyx, as the no-slip boundary condition
is now valid. This paradigm can also be explained with respect
to a classical fluid dynamics model posed by Damiano et al.
in which the presence of the EGL promotes Darcy flow in the
CFL by increasing the velocity gradients in the plasma interface,
thus increasing viscous drag forces in the CFL (Damiano, 1998;
Weinbaum et al., 2003). In addition to providing a mechanism
for themechanotransductive behavior, the presence of Darcy flow
in the CFL invalidates the no-slip condition, necessary for pipe
flow (Weinbaum et al., 2003; Tarbell and Shi, 2013). The EGL
is thought to behave as a porous material with a high hydraulic
resistance, and consequently plasma velocity through the EGL
is very limited; although RBCs essentially slide over the EGL.
Thus, degradation of the EGL could increase vascular resistance
via preventing RBCs from gliding over the vessel wall.
Enzymatic degradation of the glycocalyx directly affects
the ESL, the active composite of bound plasma constituents
attached to the EGL. The ESL per se influences blood cell-
vessel wall interactions, affects blood rheology, and determines
solute transport out of the vessel lumen. The ESL function has
been suggested to safeguard the fragile EGL from fluid shear
stress and from direct physical interactions with blood cells
(Secomb et al., 2001). Increased endothelial shear increases nitric
oxide (NO) production, dilating vessels and reducing shear stress
(Jacob et al., 2007). Additionally, it has been observed that
under shear stress, human umbilical vein endothelial cells double
the hyaluronic acid in the endothelial glycocalyx, suggesting
a secondary mechanism by which the vascular endothelium
responds to shear stress (Gouverneur et al., 2006). As the EGL
is exposed to the shear stress of the plasma layer, a function
of both the shear rate at the surface of the glycocalyx and
the plasma viscosity, the surface of the ESL is exposed to the
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FIGURE 4 | Mean cumulative distribution function during enzymatic degradation of the EGL: CDFs at baseline and at (A) 5min, (B) 20min, (C) 40min, and (D) 60min
after enzyme infusion. The blue bonding box represents the approximated thickness of the glycocalyx, and the green bounding box represents the one-tailed 99%
confidence interval of the CFL thickness.
shear stress of the adjacent whole blood. The resultant effect
on the signal transduction pathways of the endothelium could
then be combined effects of fluid shear stress on both layers.
Previous studies on relationship between the ESL in capillaries
and flowing blood demonstrate that the ESL can be highly
deformable (Long et al., 2004). However, the finite resistance to
compression of the ESL prevents direct plasma shear stress to
be generated by blood flow on endothelial cells by decreasing
plasma fluid movement within the ESL (Pries et al., 2000). The
plasma shear stress cannot be transmitted to the ESL as a fluid
shear stress; rather, the ESL transfers its shear strain to the
structures forming the ESL (Secomb et al., 2001). Enzymatically
degrading the EGL impairs transduction of plasma fluid shear
stress and solid shear stress in the ESL, which are both potential
mechanisms of endothelial shear stress mechanotransduction
(Florian et al., 2003). Therefore, endothelial cell surface shear
stress transmitted to through the ESL, or plasma fluid shear
stress within the ESL, remain plausible as the mechanism
of blood flow mediated mechanotransduction by endothelial
cells.
In addition, in capillaries, the ESL creates a large repulsive
forces that supports the movement of RBCs by acting as a
lubrication layer, which reduces capillary blood flow resistance
(Secomb et al., 1998; Feng and Weinbaum, 2000). This
observation highlights the role of the EGL in microvascular
perfusion. Pathophysiological degradation of the EGL would
increase capillary blood flow resistance by decreasing the
thickness of the lubrication layer provided by the EGL. Recent
studies have demonstrated that in chronically obese subjects,
diabetic subjects, and subjects with coronary microvascular
disease, the EGL is found to be thinner as compared to healthy
subjects, resulting in impaired vasomotor activity, increased
vascular permeability, and decreased perfusion. Additional
studies have demonstrated marked improvement in perfusion
in animal models with coronary microvascular disease by
increasing recovery of the glycocalyx with metformin and
sulodexide (van Haare et al., 2017). Therefore, as the ESL
and the glycocalyx decrease capillary blood flow resistance,
it seems plausible that pathophysiological degradation of the
EGL may play a role in decreased perfusion associated with
obesity and related pathophysiologies and influence further
progression of these pathophysiologies (van Haare et al.,
2017).
Various approaches have been used directly visualize or
estimate the EGL due to the increased recognition of its
functional importance. Groups have labeled the glycocalyx with
specific markers that attach to one or more of its components,
making them fluorescent or detectable (Vink and Duling, 1996).
This demonstrates the presence of the EGE, or its components,
but it does not establish the thickness of the EGL. Unfortunately,
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FIGURE 5 | Thickness of the CFL over time after enzymatic degradation of the EGL. (A) Fluctuations in the thickness of the CFL over time in a glass tube, at baseline,
and after enzymatic degradation of the glycocalyx. (B) Bland Altman plots comparing the difference of the CFL thickness vs. a glass tube at baseline and after
enzymatic degradation of the glycocalyx. The 95% confidence interval of the difference between the CFL of the blood vessels are illustrated with lines. The solid line
indicates the positive end of the difference between the CFL of the blood vessels and the glass tube, which remained unaltered as it is determined by the vessel wall.
The dotted line indicates the negative boundary of the difference between the CFL of the blood vessels and the glass tube, illustrates the increased erratic variations in
the CFL of the blood vessel after the glycocalyx degradation.
the EGL is easily disturbed and very vulnerable to dehydration.
Consequently, the EGL dimension is easily underestimated; early
studies estimated EGL thickness to be approximated 20 nm in
capillaries using transmission electron microscopy (TEM) (Luft,
1966). Other attempts using TEM reported the EGL to be
around 40 nm (Ueda et al., 2004). These early estimations did
not conform to experimental and theoretical estimation however,
suggesting that the EGL should be nearer 1µm (Klitzman and
Duling, 1979; Vink and Duling, 1996). The thickness of the
EGL remains controversial, as resent studies with fluorescent
labeling and high-resolution fluorescent micro-particle image
velocimetry suggest that the GGL is around 0.5µm in post-
capillary venules of the rat mesenteric and the mouse cremaster
muscle, both using intravital microscopy (Smith et al., 2003;
Gao and Lipowsky, 2010). Recently, new imaging protocols
using fluorescently tagged antibodies to heparan sulfate and
hyaluronan has revealed a much thicker EGL, over 4.0µm
in the mouse common carotid artery (Megens et al., 2007),
2.2µm in the mouse internal carotid artery (van den Berg et al.,
2009), and 2.5µm in the external carotid artery (Reitsma et al.,
2011). Most recently, cryo-TEM, which avoids the dehydration
artifacts of early TEM, has suggested that the thickness of the
EGL is of the order of 10µm on cultured endothelial cells
in vitro (Ebong et al., 2011). Therefore, the thickness of the
EGL measured from our method is in good agreement with
both the classical method for measurement of the EGL and
other indirect methods (Weinbaum et al., 2007). The approach
used in this manuscript to estimate the EGL based on the
hydrodynamic implications that the presence of the EGL has
in the thickness of the CLF relative to glass tubes of similar
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FIGURE 6 | Flow, mean velocity, and peak velocity after degradation of the EGL. Flow (Q), mean velocity (Vmean), and peak max velocity (Vmax) at (A) Baseline, and
(B) after enzymatic degradation of the glycocalyx.
diameters. The estimation of the EGL presented in here could
differ from the physical thickness of the EGL; although it
corresponds to the functional hydrodynamic layer that affect
blood flow and exchanges between the flowing blood and the
tissues.
The EGL affects blood apparent viscosity in microvessel
via the CFL thickness, which is the region with much lower
viscosity than the lumen core heavily populated with pack RBCs.
Variations in the thickness of the CFL are a consequence of both
the Fahraeus effect and the Fahraeus–Lindqvist effect (Fåhraeus,
1929). In the microvasculature (<40µm), the CFL thickness is
significant percentage of the microvessel tube diameter, resulting
in smaller microvessels having a lower relative apparent viscosity
compared to larger vessels (>40µm). The effects of the EGL
with respect to the Fahraeus effect have an impact on oxygen
flux to tissues and NO scavenging by hemoglobin in the RBCs,
as the EGL contributes to the separation of RBCs from the
vascular endothelium. The separation of blood flow between
the vessel lumen core, rich of RBCs, and the endothelium, by
the CFL zones affects oxygen delivery and NO consumption
by RBCs. Computational models for oxygen and NO transport
indicate that the CFL determines resistance to diffusion of
oxygen and NO to and from RBCs (Lamkin-Kennard et al.,
2004; Ng et al., 2015). In addition, the CFL thickness becomes
more important for controlling and enhancing oxygen release
and NO bioavailability to both the surrounding tissue and
the vascular wall in microvessels with diameters of 30µm
or less (Lamkin-Kennard et al., 2004). The glycocalyx might
have additional effects in NO transport, as it modulates
vessel wall shear stress-dependent NO production by the
endothelium.
The blood flow velocity profiles appear to be a function of the
CFL thickness, and therefore in the vessel wall shear stress on the
endothelium walls. The thickness of the CFL and its variability
is demonstrated by fluctuations in pressure about the mean,
as quantified by the standard deviation of the pressure wave.
Consequently, changes in CFL thickness counteract changes in
blood flow; as CFL thickness increases, volumetric blood flow
rate decreases. Volumetric blood flow rate also decreases as the
correlation length decreases and/or the standard deviation of
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FIGURE 7 | Velocity profiles after degradation of the EGL: (A) Systolic flow, mean velocity, and peak velocity after degradation of the glycocalyx (‡P < 0.05). (B)
Changes in flow (Q), mean velocity (Vmean), and max peak velocity (Vmax) between systole and diastole after degradation of the glycocalyx (
‡P < 0.05). (C) Baseline
velocity profiles during systole and diastole. Results were fit to the model, υ (r) = Vmax
(
1−
∣∣∣ rR
∣∣∣K
)
. During systole, Vmax = 8.8± 0.2, R = 0.48± 0.01, and
K = 4.1± 0.4. During diastole Vmax = 6.5± 0.4, R = 0.45± 0.01, and K = 3.1± 0.6. (D) Velocity profiles during systole and diastole after enzymatic degradation of
the glycocalyx. Results were fit to the model, υ (r) = Vmax
(
1−
∣∣∣ rR
∣∣∣K
)
. During systole, Vmax = 9.6± 0.5, R = 0.47± 0.01, and K = 3.4± 0.7. During diastole
Vmax = 6.7± 0.7, R = 0.43± 0.01, and K = 2.2± 0.6. (
‡P < 0.05) compared to baseline.
the amplitude increases. The mean shear rate can also increase
with fluctuations in the endothelium and the CFL. Increasing or
decreasing fluctuations in the endothelium can also extend the
entrance length (the length through which the flow regime is not
fully-developed, and shear stress statistics are constant). Thus,
blood viscosity, estimated from in vivo experiments by Poiseuille’s
law, depends not only on the rheological properties of blood,
but also by the statistical parameters that quantify endothelium
roughness.
The distribution of plasma and RBCs at the vascular wall
has traditionally been attributed to the Fahraeus effect and axial
migration of red cells (Fåhraeus, 1929). However, it is now well
established that ESL also importantly affect this distribution
(Pries et al., 2000). The ESL significantly restricts the approach
of RBCs and plasma to the vascular wall (Kim et al., 2007).
This study was conducted to evaluate the effects of the effects of
enzymatic degradation of the EGL on blood flow via preparation
of the rat cremaster muscle. We evaluated the hypothesis that
enzymatic degradation of the EGL resulted in variations and
reductions of the CFL, increased randomness of blood flow, and
variations in the observed microhemodynamics. By measuring
the change in the thickness of the CFL over time after degradation
as well as the probability distribution of RBCs as a function
of distance, it is possible to establish a relationship between
the micro hemodynamic properties of blood flow and the
EGL. Recent studies have demonstrated that the glycocalyx
influences homogenous flow distribution in the microcirculation
(McClatchey et al., 2016). In addition, many recent studies have
implicated the alterations in the mechanotransductive effects of
the EGL under different pathophysiological conditions, including
inflammation, diabetes, and atherosclerosis (Harrison et al.,
2006). As such, future studies should investigate changes in the
hemodynamics under these pathophysiological conditions that
result due to alterations in the EGL utilizing in vivomodels.
CONCLUSION
These results demonstrate that enzymatic degradation of the
EGL results in a statistically significant increase in flow and
mean velocity as well as a decrease in the bluntness of the
velocity profile in the microcirculation. In addition to providing
in vivo validation of many mathematical models that explain the
hydrodynamic effects of the EGL, these results suggest that the
EGL is responsible for alterations in blood flow in microvessels
via both the electrical and hydrodynamic fluid forces that
it produces. Future studies should investigate the changes in
hydrodynamics associated with pathophysiological alterations in
the EGL.
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